A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Boehringer Ingelheim
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
Pfizer
Pfizer
Mayo Clinic
ViroMissile, Inc.
Pfizer
Tizona Therapeutics, Inc
Clasp Therapeutics, Inc.
Baylor College of Medicine
SystImmune Inc.
UNC Lineberger Comprehensive Cancer Center
AgonOx, Inc.
Novartis
Sichuan Baili Pharmaceutical Co., Ltd.
Seagen Inc.
Degron Therapeutics Co.
Petrov, Andrey
Chongqing Precision Biotech Co., Ltd
Jonsson Comprehensive Cancer Center
Incyte Corporation
Sichuan Enray Pharmaceutical Sciences Company
Compugen Ltd
Thomas Jefferson University
Columbia University
Revolution Medicines, Inc.
National Cancer Institute (NCI)
Checkpoint Therapeutics, Inc.
Inhibrx Biosciences, Inc
Pfizer
Celldex Therapeutics
University of California, San Francisco
STCube, Inc.
Wellmarker Bio
R-Pharm
Yale University
Corvus Pharmaceuticals, Inc.
Fate Therapeutics
Cantargia AB
Prelude Therapeutics
Quadriga Biosciences, Inc.
Wellmarker Bio
Revolution Medicines, Inc.
Imperial College London
Pfizer
Incyte Corporation
Shionogi Inc.
Celgene
Canadian Cancer Trials Group